![]() |
|||
|
|
|
|
| UPDATE: February 2009 | MW: 167.23 | MF: C9H13NO2 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intravenous | domestic animal
lowest published toxic dose: 20 µg/kg (16 week pregnant)
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
AJOGAH 143,170,1982
|
intravenous | domestic animal
lowest published toxic dose: 40 µg/kg (16 week pregnant)
|
Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow)
|
AJOGAH 143,170,1982
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraarterial | man
lowest published toxic dose: 1.3 ng/kg
|
Vascular: Regional or general arteriolar constriction | Vascular: Measurement of regional blood flow
CEXPB9 27,25,2000
|
intraarterial | rat
lowest published toxic dose: 267 µg/kg
|
Vascular: Measurement of regional blood flow
|
JAPTO* 25,479,2005
|
intraduodenal | rat
lethal dose (50 percent kill): 65 mg/kg
|
N/R
|
AIPTAK 180,155,1969
|
intramuscular | mouse
lowest published toxic dose: 0.1 mg/kg
|
Biochemical: Metabolism (intermediary): Other carbohydrates
|
FATOAO 55,44,1992
|
intramuscular | mouse
lowest published toxic dose: 1 mg/kg
|
Endocrine: Hyperglycemia
|
FATOAO 55,44,1992
|
intramuscular | rabbit
lowest published toxic dose: 0.1 mg/kg
|
Biochemical: Metabolism (intermediary): Other carbohydrates
|
FATOAO 55,44,1992
|
intraperitoneal | mouse
lowest published lethal dose: 60 mg/kg
|
Cardiac: Other changes
|
JPETAB 160,22,1968
|
intraperitoneal | mouse
lowest published toxic dose: 10 mg/kg
|
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
|
JPETAB 313,310,2005
|
intrarenal | rat
lowest published toxic dose: 1 µg/kg
|
Vascular: Measurement of regional blood flow | Kidney, Ureter, and Bladder: Changes in blood vessels or in circulation of kidney
ETPAEK 59,253,2007
|
intravenous | dog
lowest published toxic dose: 8 µg/kg
|
Autonomic Nervous System: Sympathomimetic | Vascular: BP elevation not characterized in autonomic section Kidney, Ureter, and Bladder: Structural or functional change in ureter
JPETAB 300,495,2002
|
intravenous | dog
lowest published toxic dose: 50 µg/kg
|
Cardiac: EKG changes not diagnostic of above | Vascular: BP elevation not characterized in autonomic section
CEXPB9 32,805,2005
|
intravenous | man
lowest published toxic dose: 6.4 ng/kg/5 minute
|
Vascular: Regional or general arteriolar constriction | Vascular: Measurement of regional blood flow
CEXPB9 27,25,2000
|
intravenous | monkey
lowest published toxic dose: 3 µg/kg
|
Cardiac: Pulse rate decreased with fall in BP | Vascular: BP elevation not characterized in autonomic section
JPETAB 297,299,2001
|
intravenous | mouse
lethal dose (50 percent kill): 38 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Cardiac: Pulse rate increased without fall in BP Skin and Appendages: Other: Hair
APTOA6 38,474,1976
|
intravenous | mouse
lowest published toxic dose: 1 µg/kg
|
Cardiac: Change in rate | Vascular: BP elevation not characterized in autonomic section
TOXIA6 45,93,2005
|
intravenous | mouse
lowest published toxic dose: 10 µg/kg
|
Vascular: BP elevation not characterized in autonomic section
|
BJPCBM 150,29,2007
|
intravenous | pig
lowest published toxic dose: 2.5 µg/kg
|
Vascular: BP elevation not characterized in autonomic section | Vascular: Measurement of regional blood flow
EJPHAZ 418,95,2001
|
intravenous | rat
lowest published toxic dose: 100 µg/kg
|
Eye: Mydriasis (pupilliary dilation)
|
FATOAO 51,36,1988
|
intravenous | rat
lowest published toxic dose: 1 µg/kg
|
Cardiac: Change in rate | Vascular: BP elevation not characterized in autonomic section
TOXIA6 45,93,2005
|
intravenous | rat
lowest published toxic dose: 10 µg/kg
|
Kidney, Ureter, and Bladder: Changes in blood vessels or in circulation of kidney
|
JPETAB 313,1289,2005
|
intravenous | rat
lowest published toxic dose: 1 µg/kg
|
Vascular: BP elevation not characterized in autonomic section
|
JPETAB 316,95,2006
|
intravenous | rat
lowest published toxic dose: 10 µg/kg
|
Kidney, Ureter, and Bladder: Other changes
|
EJPHAZ 545,185,2006
|
intravenous | rat
lowest published toxic dose: 0.5 µg/kg
|
Cardiac: Change in rate | Cardiac: Cardiac output Vascular: BP elevation not characterized in autonomic section
CEXPB9 32,911,2005
|
intravenous | rabbit
lowest published toxic dose: 30 µg/kg
|
Eye: Mydriasis (pupilliary dilation) | Kidney, Ureter, and Bladder: Structural or functional change in ureter
AEPPAE 372,346,2006
|
ocular | child
lowest published toxic dose: 10 pph
|
Vascular: BP elevation not characterized in autonomic section | Lung, Thorax, or Respiration: Acute pulmonary edema
AJOPAA 134,624,2002
|
ocular | human
lowest published toxic dose: 10 pph
|
Brain and Coverings: Changes in circulation | Spinal Cord: Changes in circulation Behavioral: Convulsions or effect on seizure threshold
AJOPAA 134,624,2002
|
ocular | human
lowest published toxic dose: 10 pph
|
Behavioral: Headache | Cardiac: Arrythmias (indlucing changes in conduction) Vascular: BP elevation not characterized in autonomic section
AJOPAA 134,624,2002
|
ocular | infant
lowest published toxic dose: 5,500 µg/kg
|
Vascular: BP elevation not characterized in autonomic section
|
ANESAV 36,187,1972
|
ocular | woman
lowest published toxic dose: 188 µg/kg
|
Vascular: BP elevation not characterized in autonomic section
|
ANESAV 36,187,1972
|
oral | rat
lethal dose (50 percent kill): 350 mg/kg
|
N/R
|
AIPTAK 180,155,1969
|
subcutaneous | mouse
lethal dose (50 percent kill): 875 mg/kg
|
N/R
|
FATOAO 28,46,1965
|
subcutaneous | mouse
lowest published toxic dose: 10 mg/kg
|
Liver: Other changes
|
TOXID9 78,324,2004
|
subcutaneous | rat
lethal dose (50 percent kill): 28 mg/kg
|
N/R
|
JPETAB 85,119,1945
|
subcutaneous | rat
lowest published toxic dose: 12.5 mg/kg
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
TOXID9 66,24,2002
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 488,151,2001
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,5,2003
|
TOXICOLOGY REVIEW
|
|
EMMUEG 43,143,2004
|
TOXICOLOGY REVIEW
|
|
AJEMEN 22,404,2004
|
TOXICOLOGY REVIEW
|
|
APHRER 41,381,2007
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 80598; | Number of Industries 2; Total Number of Facilities 97; Number of Occupations 3; Total Number of Employees Exposed 183
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 80598 |
Number of Industries 1; Total Number of Facilities 147; Number of Occupations 5; Total Number of Employees Exposed 6,641; Total Number of Female Employees Exposed 5,606 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AJEMEN
|
American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983-
|
AJOGAH
|
American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial
Dr., St. Louis, MO 63146) V.1- 1920-
|
AJOPAA
|
American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415,
Chicago, IL 60611) Series 3: V.1- 1918-
|
ANESAV
|
Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave.,
Hagerstown, MD 21740) V.1- 1940-
|
APHRER
|
Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26-
1992-
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
BJPCBM
|
British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21
2XS, UK) V.34- 1968-
|
CEXPB9
|
Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications,
(Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ETPAEK
|
Experimental and Toxicologic Pathology. (Gustav Fischer Verlag Jena, Postfach 100537, D-07705
Jena, Germany) V.44- 1992-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
TOXIA6
|
Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPHSDY
|
Trends in Pharmacological Sciences. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1979-
|
| |